Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06669585 · ClinicalTrials.gov registry record
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
A clinical trial of Cannabis and Memory, sponsored by L. Cinnamon Bidwell.
- Recruiting
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT06669585 is a study of Cannabis and Memory that is actively recruiting participants, run by L. Cinnamon Bidwell. The registered enrollment target is 64 participants, below the 108-participant average among 24 other Cannabis trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06669585, a study of Cannabis and Memory, is actively recruiting participants, sponsored by L. Cinnamon Bidwell.
- RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Conditions Studied
Interventions
- DRUG Cannabis (smoked flower)
Study Locations (1)
Colorado
- Center for Innovation and Creativity (CINC) - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2026-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06669585
The ClinicalTrials.gov registry entry for NCT06669585 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108-participant average among 24 other Cannabis trials with a reported enrollment target (41% lower). The listed sponsor is L. Cinnamon Bidwell, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Cannabis (smoked flower) is the first listed.
NCT06669585 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06669585 about?
NCT06669585 is a clinical study titled "Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3". This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not in...
What is the current status of trial NCT06669585?
This trial is currently recruiting. The enrollment target is 64 participants. The study started on 2024-10-09. Estimated completion is 2026-01.
What conditions does trial NCT06669585 study?
This clinical trial studies the following conditions: Cannabis, Memory, Electroencephalography.
What interventions are being tested in trial NCT06669585?
The interventions under investigation include: Cannabis (smoked flower) (DRUG).
Who is sponsoring clinical trial NCT06669585?
This trial is sponsored by L. Cinnamon Bidwell, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06669585 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
RECRUITING · Phase 1
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
RECRUITING · Phase 2
-
Cannabis, HIV and Mental Processing Systems
RECRUITING
-
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
RECRUITING · NA
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.